---
title: "MicroPort CardioFlow Sets 2026 AGM, Seeks Fresh Share Buyback and Issuance Mandates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285916317.md"
description: "MicroPort CardioFlow Medtech Corp. has scheduled its annual general meeting for June 4, 2026, in Shanghai. Shareholders will review the company's financial statements and consider resolutions to authorize a share buyback of up to 10% of issued capital and the issuance of additional shares. These measures aim to enhance capital management and support future financing activities, potentially benefiting shareholder returns. MicroPort CardioFlow specializes in cardiovascular treatments and is listed on the Hong Kong Stock Exchange with a market cap of HK$3.02B."
datetime: "2026-05-11T09:39:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285916317.md)
  - [en](https://longbridge.com/en/news/285916317.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285916317.md)
---

# MicroPort CardioFlow Sets 2026 AGM, Seeks Fresh Share Buyback and Issuance Mandates

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) just unveiled an update.

MicroPort CardioFlow Medtech Corporation has called its annual general meeting for June 4, 2026, in Shanghai, where shareholders will review the company’s audited consolidated financial statements and the reports of its directors and auditors for the year ended December 31, 2025. The meeting will also ask shareholders to authorize the board to repurchase up to 10% of the company’s issued share capital and to issue additional shares and related securities, potentially giving management greater flexibility in capital management and future financing activities.

These resolutions, if approved, would allow the company to buy back shares on the Hong Kong Stock Exchange or other recognized exchanges and to issue new equity or convertible instruments during a defined mandate period. Such authorities are common among Hong Kong–listed issuers and, for MicroPort CardioFlow, may support balance-sheet optimization, liquidity management, and strategic investment or expansion plans, with implications for shareholder returns and market perception of the stock.

**More about MicroPort CardioFlow Medtech Corp.**

MicroPort CardioFlow Medtech Corporation is a medical technology company focused on cardiovascular treatments, and is listed on the Hong Kong Stock Exchange. The company develops and markets devices and therapies for heart-related conditions, serving patients and healthcare providers in China and other markets through its specialized cardiology solutions.

**Average Trading Volume:** 1,519,681

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$3.02B

For a thorough assessment of 2160 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [02160.HK](https://longbridge.com/en/quote/02160.HK.md)
- [02918.HK](https://longbridge.com/en/quote/02918.HK.md)

## Related News & Research

- [MicroPort CardioFlow Expands Overseas Distribution Via New Connected Deals](https://longbridge.com/en/news/282080762.md)
- [Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe | LUFFF Stock News](https://longbridge.com/en/news/286883156.md)
- [15:45 ET"Lean" Strengthens Saudi Arabia's Presence in Global Digital Health and Precision Medicine Ecosystems](https://longbridge.com/en/news/286811787.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [UAE among first globally to approve new obesity, hypertension treatments](https://longbridge.com/en/news/286707352.md)